Science Matters: CD47 Pathway Links To CV Disease, New Drug Development Opportunities

Initial research about inhibiting CD47 signaling on tumor cells has meant a focus on oncology drug development. New research shows that inhibiting this cell surface molecule could be used to treat atherosclerosis.